Literature DB >> 15770444

Rhinosporidiosis in Egypt: a case report and review of literature.

Mahmoud R Hussein1, Usamah M Rashad.   

Abstract

Rhinosporidiosis is an infection caused by Rhinosporidium seeberi that frequently presents as a polypoidal nasal lesions. Here, we report the first indigenous case of tumoral rhinosporidiosis in Egypt. In this case, a 25-year-old male patient from a rural background of Assuit City presented with epistaxis and a nasal polyp. The patient had not traveled abroad. The diagnosis was established on the morphological basis by the identification of 5- to 10-microm endospores and 50- to 1000-microm sporangia. The clinicopathological and immunologic features were discussed and the literature was reviewed. To the best of our knowledge this is the first case of this disease to be reported in Egypt in the human literature.

Entities:  

Mesh:

Year:  2005        PMID: 15770444     DOI: 10.1007/s11046-004-6388-y

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  12 in total

1.  Causative agent of rhinosporidiosis.

Authors:  K B Ahluwalia
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  Microcystis aeruginosa as the causative organism of rhinosporidiosis.

Authors:  S N Arseculeratne
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

3.  Nasal rhinosporidiosis in two dogs.

Authors:  N Allison; M D Willard; J Bentinck-Smith; K Davis
Journal:  J Am Vet Med Assoc       Date:  1986-04-15       Impact factor: 1.936

4.  Subcutaneous and osteolytic rhinosporidiosis.

Authors:  S Gokhale; V C Ohri; H Subramanya; P S Reddy; S C Sharma
Journal:  Indian J Pathol Microbiol       Date:  1997-01       Impact factor: 0.740

5.  Further African cases of rhinosporidiosis.

Authors:  P Gigase; P Kestelyn
Journal:  Ann Soc Belg Med Trop       Date:  1993-06

6.  Rhinosporidiosis: a study that resolves etiologic controversies.

Authors:  K B Ahluwalia; N Maheshwari; R C Deka
Journal:  Am J Rhinol       Date:  1997 Nov-Dec

7.  Cell-mediated immune responses (CMIR) in human rhinosporidiosis.

Authors:  N R de Silva; H Huegel; D N Atapattu; S N Arseculeratne; R Kumarasiri; S Gunawardena; P Balasooriya; R Fernando
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

Review 8.  Disseminated cutaneous rhinosporidiosis.

Authors:  D M Thappa; S Venkatesan; C S Sirka; T J Jaisankar; C Ratnakar
Journal:  J Dermatol       Date:  1998-08       Impact factor: 4.005

Review 9.  Rhinosporidiosis: a description of an unprecedented outbreak in captive swans (Cygnus spp.) and a proposal for revision of the ontogenic nomenclature of Rhinosporidium seeberi.

Authors:  F A Kennedy; R R Buggage; L Ajello
Journal:  J Med Vet Mycol       Date:  1995 May-Jun

10.  Rhinosporidium seeberi: a human pathogen from a novel group of aquatic protistan parasites.

Authors:  D N Fredricks; J A Jolley; P W Lepp; J C Kosek; D A Relman
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

View more
  4 in total

1.  Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.

Authors:  M R Hussein; D A H Elsers; S A Fadel; A-E M Omar
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

2.  Nasal rhinosporidiosis masquerading as pyogenic granuloma in a pediatric patient at a Zonal Referral Hospital in Central Tanzania: Case report.

Authors:  Zephania Saitabau Abraham; Francis Zerd; Aveline Aloyce Kahinga
Journal:  Clin Case Rep       Date:  2022-06-19

3.  Cylindrical Cell Papilloma (Oncocytic Schneiderian Papilloma): Clinicopathological Study of Five Cases.

Authors:  Abdulla Darwish; Amal Al-Abdulla
Journal:  Oman Med J       Date:  2012-09

4.  Clinicopathological study of rhinosporidiosis with special reference to cytodiagnosis.

Authors:  Anuradha Sinha; Jyoti P Phukan; Gautam Bandyopadhyay; Sanjay Sengupta; Kingshuk Bose; Rajib K Mondal; Manoj K Choudhuri
Journal:  J Cytol       Date:  2012-10       Impact factor: 1.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.